Перегляд вихідного коду сторінки Various Lethal Selisistat Errors You May End Up Doing

The stage of progress F2 (selectively reported) is definite for the end of our data collection;  later publications can still fill the remaining gaps by moving trials to F1 ([http://www.selleckchem.com/products/ABT-888.html ABT-888 research buy] completely reported). Figure?1 Overview of stages of progress of the 2007 inception cohort of clinical drug trials in the Netherlands. The numbers in the boxes indicate the numbers of trials that succeeded to the specific stages of progress. From B1, C1, D1, E1 to F1 is the ��perfect�� ... Non-publication We search for publications on the trial results in the scientific literature using a standardised algorithm (figure 2). A publication is defined as a peer-reviewed article containing at least methods and results. All reports not fulfilling this publication (eg, results reported in registries, conference abstracts containing results, trial summaries on sponsor websites containing methods and results) will be also collected. Peer-reviewed publication is in our opinion the golden standard for reporting clinical research, but trial results can be reported by other means (eg, registries, sponsor websites, conference abstracts). Using only peer-reviewed articles as end point for non-publication is in line with the majority of other research.47 If we identify more than one publication of trial results, we classify the publication as either primary (ie, containing the overall results and conclusions) or secondary (ie, interim, post hoc, subgroup or other analysis). In general, we assume that this will be clearly stated in the publications.42  Other information collected includes the full-text of the article, the journal and the first date of publication (eg, advance online publication). We have completed this part of the publication search in March 2015. Figure?2 Publication search algorithm. EudraCT, European Union Drug Regulating Authorities Clinical Trials: obligatory registration database for clinical drug trials carried out in the European Union. We will also collect the end of trial date and information about (early) termination of the trial. We define the  end of trial date as the date of the last visit of the last patient undergoing the trial.50 A trial is terminated early if either the inclusion or the follow-up is terminated earlier than foreseen in the research protocol. Since early termination is an intermediate stage of progress of a trial, we include early termination as a potential determinant for the end points studied. In addition, prospective registration on clinicaltrials.gov will be examined as a potential determinant (table 1). We define prospective registration as registration of the trial before the first patient is recruited.1 The data field ��first received�� on clinicaltrials.gov will be used as the date of registration.